Michaele C. Christian

Author

Also Known As

Christian, Michaele, Dlffer, M C Christian, M Christian, M. C. Christian, M. Christian, M.C. Christian, MICHAELE C. CHRISTIAN, Macedonia Maj Christian, Michaele C Christian

Publications

22.5K

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute National Institutes of Health National Cancer Institute Johns Hopkins University Memorial Sloan Kettering Cancer Center

About

Michaele C. Christian is an author at National Cancer Institute specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	17.6K
2	Health Sciences	3	3	16.6K
3	Public Health	2	2	451
4	Biomolecular Engineering	1	1	15
5	Biostatistics	1	1	15.7K

Michaele C. Christian

Publications

20.9K

Citations

H-Index

Page 1

	Year	Citations
New Guidelines to Evaluate the Response to Treatment in Solid Tumors Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer, JNCI Journal of the National Cancer Institute World Health OrganizationSolid TumorsCancer ManagementMetronomic ChemotherapyResponse Assessment	2000	15.7K
Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials J I Johnson, Shannon Decker, Daniel Zaharevitz, British Journal of Cancer	2001	850
New guidelines to evaluate the response to treatment in solid tumors Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer, Breast Cancer Solid TumorsMedicineCancer ManagementNew GuidelinesCancer Treatment	2005	662
Accelerated Titration Designs for Phase I Clinical Trials in Oncology Richard Simon, Larry Rubinstein, Susan G. Arbuck, JNCI Journal of the National Cancer Institute	1997	632
How Sociodemographics, Presence of Oncology Specialists, and Hospital Cancer Programs Affect Accrual to Cancer Treatment Trials Edward L. Trimble, Jeffrey S. Abrams, Otis W. Brawley, Journal of Clinical Oncology	2002	526
Cardiac disturbances during the administration of taxol. Eric K. Rowinsky, William P. McGuire, Thomas Guarnieri, Journal of Clinical Oncology Heart FailureChemoprevention StrategyCardiac DisturbancesCardiovascular PharmacologyPathology	1991	395
A comparison of two phase I trial designs Edward L. Korn, Douglas Midthune, T. Timothy Chen, Statistics in Medicine	1994	299
Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103. Edward L. Trimble, Jascha Adams, D. Vena, Journal of Clinical Oncology	1993	272
Phase I Clinical Trial Design in Cancer Drug Development Elizabeth A. Eisenhauer, Peter J. O’Dwyer, Michaele C. Christian, Journal of Clinical Oncology MedicinePharmacologyClinical TrialsPharmacotherapyCancer Drug Development	2000	235
A reassessment of cardiac toxicity associated with Taxol. Susan G. Arbuck, H. William Strausś, Eric K. Rowinsky, PubMed OncologyChemoprevention StrategyCardiovascular DiseaseMedicineCardiovascular Pharmacology	1993	197

Page 1